hg_175382.1

Basic information about the TSS

---

TSS ID: hg_175382.1 Species: human Chr: chr19		Start: 35745563 End: 35745574 Strand: +
TSS cluster detected*

  * The number of TSS cluster called studies (maximum 16)

Gene and protein annotation

---

Transcript_name: ENST00000591949.1 Distance: 26 GeneID: 55851 HGNC/MGI_ID: HGNC:30100 UniProt_ID: K7ES79

Gene_name: presenilin enhancer, gamma-secretase subunit Gene_symbol: PSENEN Gene_synonyms: PEN2 Gene_source: HGNC:30100

TATA-Box annotation

---

Distance to TSS:	-82
Nearest PromoterID:	NM_001281532
Entrez ID:	55851
Nearest Unigene:	Hs.534465
Nearest Refseq:	NM_172341
Nearest Ensembl:	ENSG00000205155
Gene Name:	presenilin enhancer, gamma-secretase subunit
Gene Alias:	ACNINV2|MDS033|MSTP064|PEN-2|PEN2
Gene Description:	presenilin enhancer, gamma-secretase subunit
Gene Type:	protein-coding
CpG%:	0.09
GC%:	0.606965
TATA-Box(TBP)/Promoter/Homer Distance From TSS(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@PSENEN p3@PSENEN p4@PSENEN
Sample		p1@PSENEN	p3@PSENEN	p4@PSENEN
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	46.17	4.68	10.32
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	60.29	7.89	10.32
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	60.76	8.10	9.84
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	52.81	7.28	11.44
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	54.67	7.87	11.92
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	55.04	7.56	9.88
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	64.93	15.47	14.82
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	63.46	10.17	16.71
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	69.89	11.33	14.32
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	52.17	10.43	11.01
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	46.08	6.87	15.36
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	43.50	5.29	12.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	40.94	1.45	2.10
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	42.25	1.95	3.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	36.01	1.54	2.85
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	47.78	1.26	1.76
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	39.75	1.75	1.09
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	56.10	2.11	1.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	51.72	1.07	1.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	45.88	2.11	1.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	47.71	1.74	1.87
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	50.23	2.07	1.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	37.48	2.20	1.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	42.22	1.21	2.43
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	38.70	1.81	2.06
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	48.43	1.58	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	39.56	2.75	1.10
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	41.73	3.30	2.12
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	49.91	1.45	2.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	41.08	0.90	1.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	46.89	1.67	2.51
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	47.48	1.95	1.76
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	57.82	2.32	2.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	69.77	2.14	5.11
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	39.64	1.68	2.06
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	39.09	1.53	1.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	48.85	1.23	2.25
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	37.28	1.81	1.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	52.94	2.97	2.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	47.77	2.40	1.92
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	43.76	1.18	1.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	54.75	2.34	1.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	38.59	0.84	1.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	46.85	2.27	2.10
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	42.16	1.61	1.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	46.99	2.33	1.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	40.54	0.96	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	50.97	2.98	2.38
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	57.69	3.59	1.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	52.57	2.43	2.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	56.98	2.05	1.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	62.71	2.67	1.78
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	111.94	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	54.65	3.19	1.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	50.70	5.30	1.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	71.31	1.68	1.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	85.88	1.84	4.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	51.86	3.89	3.89
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	52.03	2.89	0.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	82.35	3.14	5.34
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	55.70	2.12	1.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	56.64	2.80	2.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	90.76	3.98	3.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	84.94	3.06	2.04
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	43.21	1.95	1.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	63.90	2.13	1.06
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	48.49	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	78.97	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	47.29	3.41	0.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	54.55	4.46	2.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	50.20	4.22	2.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	54.31	3.31	2.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	33.72	0.93	0.93
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	38.83	2.14	2.14
Adipocyte - breast, donor1	11376-118A8	45.77	2.69	2.06
Adipocyte - breast, donor2	11327-117E4	27.75	0.96	2.57
Adipocyte - omental, donor1	11473-119C6	42.62	2.54	2.16
Adipocyte - omental, donor2	11474-119C7	43.35	1.49	4.48
Adipocyte - omental, donor3	11475-119C8	42.53	2.01	1.00
Adipocyte - perirenal, donor1	11476-119C9	56.14	3.83	3.83
Adipocyte - subcutaneous, donor1	11259-116F8	68.17	4.40	1.10
Adipocyte - subcutaneous, donor2	11336-117F4	63.68	4.06	1.35
Adipocyte - subcutaneous, donor3	11408-118E4	45.70	1.74	3.13
Adipocyte differentiation, day04, donor1	13019-139D4	25.03	1.37	1.56
Adipocyte differentiation, day04, donor2	13022-139D7	30.37	0.77	0.77
Adipocyte differentiation, day04, donor3	13025-139E1	27.04	1.39	0.28
Adipocyte differentiation, day04, donor4	13028-139E4	21.16	0.59	1.18
Adipocyte differentiation, day08, donor1	13020-139D5	21.96	0.88	1.53
Adipocyte differentiation, day08, donor2	13023-139D8	34.21	0.65	1.29
Adipocyte differentiation, day08, donor3	13026-139E2	25.59	1.07	1.07
Adipocyte differentiation, day08, donor4	13029-139E5	22.81	1.67	1.11
Adipocyte differentiation, day12, donor1	13021-139D6	43.25	1.25	1.66
Adipocyte differentiation, day12, donor2	13024-139D9	31.65	1.51	1.00
Adipocyte differentiation, day12, donor3	13027-139E3	18.33	1.64	2.29
Adipocyte differentiation, day12, donor4	13030-139E6	22.84	0.30	0.61
Alveolar Epithelial Cells, donor1	11510-119G7	72.71	7.73	1.99
Alveolar Epithelial Cells, donor2	11590-120G6	108.65	10.40	6.45
Alveolar Epithelial Cells, donor3	11671-122G6	40.73	4.79	2.40
Amniotic Epithelial Cells, donor1	11533-120A3	67.10	7.02	5.58
Amniotic Epithelial Cells, donor2	11613-122A2	63.59	3.35	1.67
Amniotic Epithelial Cells, donor3	11694-123A2	59.99	5.14	3.49
Anulus Pulposus Cell, donor1	11248-116E6	73.35	2.98	2.52
Anulus Pulposus Cell, donor2	11463-119B5	53.88	1.47	2.94
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	48.97	7.19	2.25
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	67.29	1.74	6.08
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	57.79	8.56	10.70
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	48.72	3.59	2.39
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	49.32	7.59	5.06
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	74.59	5.28	2.64
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	60.43	2.27	7.80
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	66.02	4.37	7.77
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	67.70	2.38	4.75
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	61.39	4.14	4.14
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	76.20	5.08	3.63
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	72.72	2.51	2.51
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	64.41	3.62	4.45
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	73.70	6.82	4.09
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	71.63	7.39	4.52
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	53.58	5.36	3.75
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	53.28	2.65	2.83
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	51.32	3.21	3.21
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	67.31	3.90	3.90
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	53.41	2.99	3.98
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	72.04	4.80	7.20
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	81.42	3.54	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	51.97	4.46	1.72
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	79.70	0.00	4.19
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	67.96	3.40	4.37
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	65.27	3.79	3.79
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	52.09	4.85	6.06
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	80.37	5.13	3.42
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	59.43	4.06	4.28
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	57.30	4.65	5.68
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	61.47	6.10	6.10
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	48.23	4.82	3.22
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	59.93	7.85	3.57
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	52.06	3.51	6.43
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	57.81	3.91	3.31
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	71.28	4.75	3.56
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	71.20	4.58	3.56
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	59.34	5.86	4.08
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	63.54	4.45	4.45
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	64.30	2.59	3.45
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	61.18	5.50	2.75
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	57.71	6.09	3.48
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	58.57	10.39	1.89
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	47.47	4.41	3.39
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	60.23	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	73.94	6.34	6.34
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	54.25	3.65	2.57
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	57.16	1.80	3.61
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	66.34	5.83	4.37
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	61.15	4.37	5.06
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	61.21	7.65	5.10
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	87.71	6.86	6.36
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	66.89	3.51	3.51
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	50.80	4.90	3.37
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	80.31	5.26	3.35
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	59.65	4.88	3.33
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	51.88	3.05	7.63
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	74.22	8.86	4.43
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	57.99	4.24	3.44
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	64.69	2.54	2.54
Astrocyte - cerebellum, donor1	11500-119F6	77.13	5.04	5.90
Astrocyte - cerebellum, donor2	11580-120F5	62.47	4.11	3.59
Astrocyte - cerebellum, donor3	11661-122F5	52.23	5.24	4.40
Astrocyte - cerebral cortex, donor1	11235-116D2	51.59	4.18	3.49
Astrocyte - cerebral cortex, donor2	11316-117D2	49.18	4.37	1.94
Astrocyte - cerebral cortex, donor3	11392-118C6	42.96	6.26	3.58
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	17.20	2.18	2.41
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	17.41	1.88	2.38
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	14.34	2.05	2.28
Basophils, donor1	12241-129G9	52.83	0.52	0.26
Basophils, donor2	12242-129H1	47.99	1.08	0.72
Basophils, donor3	12243-129H2	33.66	0.59	0.15
Bronchial Epithelial Cell, donor1	11511-119G8	47.43	3.02	1.94
Bronchial Epithelial Cell, donor2	11591-120G7	72.69	5.03	2.74
Bronchial Epithelial Cell, donor3	11672-122G7	50.21	0.00	7.17
Bronchial Epithelial Cell, donor4	11453-119A4	57.12	1.26	3.14
Bronchial Epithelial Cell, donor5	11457-119A8	56.56	3.33	2.70
Bronchial Epithelial Cell, donor6	11461-119B3	43.06	2.99	2.76
Bronchial Epithelial Cell, donor7	11769-123I5	31.13	1.80	2.16
Burkitt's lymphoma cell line:DAUDI	10422-106C8	26.18	2.68	2.16
Burkitt's lymphoma cell line:RAJI	10476-106I8	31.21	2.56	2.10
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	103.61	0.96	2.56
CD133+ stem cells - cord blood derived, pool1	12223-129E9	31.03	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	45.08	0.56	0.56
CD14+ Monocytes, donor2	11305-117B9	42.69	0.19	0.37
CD14+ Monocytes, donor3	11381-118B4	39.30	0.22	0.00
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	78.69	1.98	1.13
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	45.87	0.38	0.38
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	45.37	0.00	0.33
CD14+ monocytes - mock treated, donor1	11863-125A9	35.85	0.43	0.29
CD14+ monocytes - mock treated, donor2	11873-125C1	20.52	0.60	0.00
CD14+ monocytes - mock treated, donor3	11883-125D2	30.56	0.24	0.24
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	25.11	0.50	0.00
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	16.84	0.28	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	27.02	0.00	0.00
CD14+ monocytes - treated with BCG, donor1	11860-125A6	40.73	0.78	0.20
CD14+ monocytes - treated with BCG, donor2	11870-125B7	29.20	0.53	0.18
CD14+ monocytes - treated with BCG, donor3	11880-125C8	65.94	0.65	0.44
CD14+ monocytes - treated with Candida, donor1	11868-125B5	21.54	0.00	0.23
CD14+ monocytes - treated with Candida, donor2	11878-125C6	11.09	0.53	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	15.53	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	29.60	0.89	0.15
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	21.35	0.40	0.20
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	55.80	1.46	0.00
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	33.40	0.69	0.00
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	22.17	0.00	0.23
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	29.24	0.44	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	52.18	0.54	0.54
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	36.11	0.35	0.17
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	41.24	0.84	0.42
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	26.45	0.18	0.18
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	11.98	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	15.79	0.88	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	36.44	1.22	0.17
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	28.25	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	61.86	0.00	0.22
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	22.93	0.00	0.41
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	14.37	0.70	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	33.17	0.23	0.23
CD14+CD16+ Monocytes, donor1	11789-124B7	116.17	0.44	0.65
CD14+CD16+ Monocytes, donor2	11801-124D1	121.27	1.15	0.23
CD14+CD16+ Monocytes, donor3	11912-125G4	150.76	0.65	0.43
CD14+CD16- Monocytes, donor1	11788-124B6	109.94	0.31	0.62
CD14+CD16- Monocytes, donor2	11799-124C8	95.01	0.52	0.00
CD14+CD16- Monocytes, donor3	11910-125G2	56.41	0.00	0.67
CD14-CD16+ Monocytes, donor1	11790-124B8	168.93	2.30	0.26
CD14-CD16+ Monocytes, donor2	11800-124C9	120.54	1.54	0.44
CD14-CD16+ Monocytes, donor3	11911-125G3	125.27	1.05	0.42
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	75.20	6.10	2.03
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	48.81	2.71	5.42
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	60.06	5.18	9.32
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	109.27	2.13	5.86
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	65.40	0.00	4.29
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	66.68	4.91	7.72
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	71.38	1.57	6.27
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	102.83	3.95	6.59
CD19+ B Cells, donor1	11544-120B5	36.16	1.64	2.47
CD19+ B Cells, donor2	11624-122B4	34.82	0.00	2.18
CD19+ B Cells, donor3	11705-123B4	30.79	0.50	3.03
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	68.29	4.04	0.81
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	74.70	6.39	1.60
CD34+ Progenitors, donor1	11545-120B6	46.19	2.01	1.00
CD34+ Progenitors, donor2	11625-122B5	17.98	0.00	1.12
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	81.54	0.38	1.13
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	111.16	2.48	2.93
CD4+ T Cells, donor1	11225-116C1	20.00	0.00	1.07
CD4+ T Cells, donor2	11306-117C1	34.29	0.00	1.22
CD4+ T Cells, donor3	11382-118B5	26.23	0.30	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	67.13	0.00	1.02
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	86.47	0.67	1.12
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	83.94	1.15	0.86
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	56.42	0.47	1.42
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	68.83	0.00	2.11
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	56.04	6.59	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	56.36	1.01	1.45
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	67.95	1.02	0.68
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	64.80	2.10	0.97
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	60.97	0.90	1.79
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	86.30	0.35	1.75
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	61.60	1.32	1.76
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	78.43	0.84	1.69
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	61.71	0.42	1.45
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	78.52	1.34	1.34
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	41.61	0.54	1.36
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	46.09	0.00	1.61
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	37.66	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	67.50	0.93	1.30
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	81.66	1.73	0.87
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	87.63	1.89	1.47
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	82.92	2.02	2.53
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	100.08	0.87	2.17
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	55.35	0.00	2.18
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	66.31	0.49	2.47
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	86.78	0.92	2.77
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	121.44	1.40	5.58
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	61.20	0.28	1.11
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	57.42	1.23	2.21
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	64.68	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	78.07	1.43	1.43
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	101.10	2.77	1.38
CD8+ T Cells, donor1	11226-116C2	32.41	0.00	0.65
CD8+ T Cells, donor2	11307-117C2	32.29	0.00	0.38
CD8+ T Cells, donor3	11383-118B6	31.81	0.00	1.51
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	53.68	5.96	12.16
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	52.48	6.23	8.87
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	65.39	10.67	14.77
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	65.75	13.21	14.71
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	58.08	7.44	16.08
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	61.62	6.59	13.87
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	53.02	8.04	9.78
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	60.80	6.58	10.79
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	63.55	6.10	11.96
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	61.88	9.06	13.89
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	72.63	10.75	12.78
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	62.88	7.19	9.86
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	47.71	4.82	12.26
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	53.74	5.47	12.75
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	41.02	5.97	7.46
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	65.19	5.04	18.37
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	55.82	6.33	10.07
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	43.37	8.96	12.02
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	64.33	9.51	12.36
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	54.13	8.30	11.99
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	58.03	8.34	13.79
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	60.05	5.74	13.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	49.26	4.73	14.98
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	60.51	7.56	9.83
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	80.30	7.23	12.85
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	82.53	9.79	17.49
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	83.15	10.02	19.03
Cardiac Myocyte, donor1	11525-119I4	45.69	5.48	0.00
Cardiac Myocyte, donor2	11605-120I3	80.54	5.93	1.48
Cardiac Myocyte, donor3	11686-122I3	49.35	4.63	2.53
Chondrocyte - de diff, donor1	11261-116G1	44.37	2.43	1.04
Chondrocyte - de diff, donor2	11338-117F6	47.62	1.78	2.84
Chondrocyte - de diff, donor3	11410-118E6	46.54	2.28	3.41
Chondrocyte - re diff, donor2	11339-117F7	53.72	2.69	4.48
Chondrocyte - re diff, donor3	11411-118E7	55.00	2.02	2.02
Ciliary Epithelial Cells, donor1	11242-116D9	53.02	4.59	2.75
Ciliary Epithelial Cells, donor2	11323-117D9	63.70	5.13	5.56
Ciliary Epithelial Cells, donor3	11399-118D4	44.43	4.07	2.30
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	146.81	5.78	2.38
Corneal Epithelial Cells, donor1	11526-119I5	47.65	4.61	1.98
Corneal Epithelial Cells, donor2	11606-120I4	52.33	5.69	2.28
Corneal Epithelial Cells, donor3	11687-122I4	53.17	4.86	2.30
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	55.47	2.15	0.33
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	65.61	2.84	1.26
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	86.27	10.35	3.45
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	63.93	3.46	1.51
Dendritic Cells - plasmacytoid, donor1	11228-116C4	80.63	3.42	2.05
Dendritic Cells - plasmacytoid, donor2	11309-117C4	141.02	4.57	1.96
Dendritic Cells - plasmacytoid, donor3	11385-118B8	98.72	3.39	3.87
Endothelial Cells - Aortic, donor0	11207-116A1	39.69	4.67	2.00
Endothelial Cells - Aortic, donor1	11263-116G3	51.64	5.28	1.76
Endothelial Cells - Aortic, donor2	11340-117F8	42.14	3.39	2.55
Endothelial Cells - Aortic, donor3	11412-118E8	37.75	2.75	2.75
Endothelial Cells - Artery, donor1	11264-116G4	49.45	2.62	2.04
Endothelial Cells - Artery, donor2	11341-117F9	38.12	11.06	5.41
Endothelial Cells - Artery, donor3	11413-118E9	46.81	3.86	3.33
Endothelial Cells - Lymphatic, donor1	11236-116D3	41.45	1.55	0.89
Endothelial Cells - Lymphatic, donor2	11317-117D3	33.47	1.83	1.52
Endothelial Cells - Lymphatic, donor3	11393-118C7	24.24	1.69	1.69
Endothelial Cells - Microvascular, donor1	11265-116G5	45.16	1.19	2.38
Endothelial Cells - Microvascular, donor2	11342-117G1	48.94	4.17	2.60
Endothelial Cells - Microvascular, donor3	11414-118F1	38.71	2.69	3.12
Endothelial Cells - Thoracic, donor1	11266-116G6	37.61	3.20	3.20
Endothelial Cells - Thoracic, donor2	11343-117G2	57.13	3.14	5.24
Endothelial Cells - Umbilical vein, donor1	11243-116E1	42.62	2.86	2.48
Endothelial Cells - Umbilical vein, donor2	11324-117E1	24.77	1.52	1.30
Endothelial Cells - Umbilical vein, donor3	11400-118D5	20.64	1.95	0.85
Endothelial Cells - Vein, donor1	11267-116G7	53.46	3.41	1.14
Endothelial Cells - Vein, donor2	11344-117G3	42.61	4.19	0.00
Endothelial Cells - Vein, donor3	11416-118F3	43.96	3.77	1.57
Eosinophils, donor1	12244-129H3	0.00	0.00	15.25
Eosinophils, donor2	12245-129H4	56.11	4.95	0.00
Eosinophils, donor3	12246-129H5	89.17	7.13	3.57
Esophageal Epithelial Cells, donor1	11507-119G4	39.58	1.71	1.95
Esophageal Epithelial Cells, donor2	11587-120G3	33.28	4.16	4.16
Esophageal Epithelial Cells, donor3	11668-122G3	48.81	0.00	32.54
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	36.95	2.87	0.82
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	65.80	5.04	4.27
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	17.33	1.08	2.28
Fibroblast - Aortic Adventitial, donor1	11245-116E3	46.57	4.24	3.27
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	27.02	2.59	1.50
Fibroblast - Aortic Adventitial, donor2	11326-117E3	31.43	2.64	1.16
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	63.76	3.16	5.01
Fibroblast - Aortic Adventitial, donor3	11401-118D6	37.87	2.99	3.65
Fibroblast - Cardiac, donor1	11268-116G8	53.53	0.91	2.27
Fibroblast - Cardiac, donor2	11345-117G4	42.45	3.79	4.55
Fibroblast - Cardiac, donor3	11417-118F4	67.19	4.57	4.57
Fibroblast - Cardiac, donor4	11452-119A3	23.04	1.52	1.82
Fibroblast - Cardiac, donor5	11456-119A7	38.58	2.92	0.89
Fibroblast - Cardiac, donor6	11460-119B2	41.39	2.58	1.82
Fibroblast - Choroid Plexus, donor1	11492-119E7	57.35	1.61	2.95
Fibroblast - Choroid Plexus, donor2	11572-120E6	54.36	3.02	1.73
Fibroblast - Choroid Plexus, donor3	11653-122E6	43.94	8.79	1.46
Fibroblast - Conjunctival, donor1	11531-120A1	90.41	11.07	2.77
Fibroblast - Conjunctival, donor3	11692-122I9	57.84	1.53	2.04
Fibroblast - Dermal, donor1	11269-116G9	47.43	3.29	2.82
Fibroblast - Dermal, donor2	11346-117G5	51.88	5.66	4.72
Fibroblast - Dermal, donor3	11418-118F5	45.94	3.02	2.42
Fibroblast - Dermal, donor4	11450-119A1	29.28	2.26	2.03
Fibroblast - Dermal, donor5	11454-119A5	40.12	5.58	3.31
Fibroblast - Dermal, donor6	11458-119A9	38.66	3.74	4.71
Fibroblast - Gingival, donor1	11237-116D4	38.11	1.46	0.83
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	45.59	2.62	1.83
Fibroblast - Gingival, donor2	11318-117D4	47.84	4.61	2.24
Fibroblast - Gingival, donor3	11394-118C8	32.78	0.77	1.06
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	44.67	2.08	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	32.77	1.76	1.59
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	48.48	3.43	2.34
Fibroblast - Gingival, donor6 (control)	11922-125H5	50.85	3.38	1.89
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	36.70	3.88	2.47
Fibroblast - Gingival, donor7 (control)	11924-125H7	54.84	2.05	0.88
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	44.72	3.00	2.05
Fibroblast - Gingival, donor8 (control)	11926-125H9	43.88	4.94	1.97
Fibroblast - Gingival, donor9 (control)	11927-125I1	47.25	1.61	1.32
Fibroblast - Lung, donor1	11270-116H1	48.94	2.72	0.00
Fibroblast - Lung, donor2	11347-117G6	35.81	1.49	0.00
Fibroblast - Lung, donor3	11419-118F6	57.82	3.59	2.32
Fibroblast - Lymphatic, donor1	11506-119G3	58.31	2.50	0.83
Fibroblast - Lymphatic, donor2	11586-120G2	32.17	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	55.14	3.64	1.12
Fibroblast - Mammary, donor1	11540-120B1	44.25	4.47	3.25
Fibroblast - Mammary, donor2	11620-122A9	79.88	0.00	3.99
Fibroblast - Mammary, donor3	11701-123A9	41.69	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	53.15	5.43	1.55
Fibroblast - Periodontal Ligament, donor2	11319-117D5	30.34	5.46	1.97
Fibroblast - Periodontal Ligament, donor3	11395-118C9	25.70	0.92	2.14
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	26.33	2.67	1.14
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	53.73	4.05	3.51
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	26.79	0.93	1.28
Fibroblast - Pulmonary Artery, donor1	11250-116E8	72.62	6.63	3.09
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	59.74	5.08	3.86
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	74.84	5.35	3.34
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	66.42	1.19	3.56
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	42.27	2.98	3.18
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	43.87	1.42	1.78
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	38.04	1.97	2.96
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	40.92	2.41	3.31
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	32.17	1.73	1.51
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	26.57	2.28	2.28
Fibroblast - skin normal, donor1	11553-120C5	42.33	1.31	2.30
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	26.07	4.81	1.00
Fibroblast - skin normal, donor2	11561-120D4	41.09	3.11	3.52
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	38.08	0.91	2.72
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	43.99	2.82	1.99
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	39.32	1.54	2.05
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	38.43	2.96	2.30
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	50.92	5.01	2.77
Fibroblast - skin walker warburg, donor1	11554-120C6	53.47	4.55	3.54
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	107.26	5.96	5.18
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	110.80	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	26.15	1.74	0.87
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	52.35	4.68	2.43
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	46.06	4.42	1.82
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	34.75	4.09	2.04
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	71.96	3.83	3.06
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	95.71	8.29	3.83
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	90.14	5.99	5.71
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	67.28	3.03	2.76
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	54.34	4.57	3.20
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	56.07	4.16	4.16
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	62.38	2.11	2.38
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	41.42	2.94	1.96
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	68.54	4.86	3.54
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	45.36	2.97	1.41
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	46.92	1.35	1.85
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	48.89	3.76	1.88
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	32.96	2.48	1.24
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	38.62	2.21	1.52
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	37.00	2.24	2.24
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	48.15	3.65	2.05
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	42.60	2.74	1.99
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	39.13	2.40	1.09
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	61.76	3.84	2.36
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	46.57	2.54	2.38
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	43.79	2.23	2.01
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	48.59	2.42	1.21
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	54.79	2.21	3.56
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	42.12	3.81	1.86
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	29.34	1.77	1.56
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	31.42	1.88	2.22
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	47.03	2.32	2.21
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	40.43	2.66	1.75
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	45.74	1.84	1.84
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	57.35	3.71	4.54
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	44.73	2.77	2.08
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	55.53	3.00	2.17
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	43.87	1.32	1.54
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	49.93	2.58	3.44
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	49.76	3.08	2.27
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	56.13	1.28	1.60
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	45.96	2.56	2.37
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	52.20	3.64	2.37
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	57.47	1.52	3.04
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	49.86	3.35	1.67
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	58.84	2.85	2.63
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	63.97	3.93	2.81
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	31.11	1.57	1.48
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	66.05	3.48	2.14
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	52.17	1.84	1.53
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	48.71	3.50	1.55
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	63.43	4.07	1.08
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	55.86	2.58	0.55
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	58.56	2.41	3.51
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	34.71	1.98	3.97
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	53.29	2.37	1.71
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	45.80	2.22	1.01
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	20.08	0.76	0.25
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	33.24	0.80	0.80
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	43.76	1.39	1.23
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	48.69	1.43	1.43
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	123.92	8.76	4.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	124.04	7.35	3.67
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	75.18	4.15	3.23
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	131.16	7.42	4.95
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	111.01	7.74	5.80
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	137.98	9.63	6.42
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	93.90	5.22	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	108.71	6.51	4.56
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	97.19	6.18	3.71
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	53.32	3.33	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	85.85	5.03	3.08
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	79.42	6.86	2.94
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	67.11	5.87	5.87
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	77.61	5.41	3.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	93.07	2.38	5.09
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	152.43	4.18	6.26
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	85.90	6.30	6.87
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	92.05	3.85	2.37
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	101.65	8.47	1.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	99.82	4.56	3.31
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	80.08	5.75	4.83
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	126.44	0.00	5.27
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	70.35	3.84	4.61
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	79.21	3.91	3.26
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	105.01	4.68	2.01
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	95.16	1.16	3.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	73.60	3.08	2.74
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	79.51	4.97	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	85.40	3.30	1.42
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	82.68	2.41	1.81
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	93.09	4.58	3.05
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	86.15	4.79	5.58
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	85.35	1.97	3.95
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	116.86	2.36	2.36
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	96.27	4.08	5.25
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	55.74	3.51	2.19
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	79.68	0.00	0.85
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	71.63	5.37	1.79
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	98.99	4.37	2.91
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	94.73	5.71	3.42
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	65.70	5.82	1.66
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	96.70	7.87	2.25
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	40.60	1.90	1.27
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	58.07	3.76	4.18
Hep-2 cells mock treated, biol_rep1	11898-125E8	57.21	5.57	5.34
Hep-2 cells mock treated, biol_rep2	11899-125E9	57.56	6.58	4.56
Hep-2 cells mock treated, biol_rep3	11900-125F1	51.64	7.51	3.41
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	67.22	6.56	4.37
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	54.59	8.81	6.66
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	54.47	7.53	5.60
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	54.42	6.85	4.11
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	58.67	6.69	4.12
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	61.51	4.81	6.73
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	46.45	1.68	2.80
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	58.43	4.33	3.03
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	71.38	10.58	2.64
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	71.60	4.59	3.17
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	62.48	5.81	2.91
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	66.79	6.29	2.97
Hepatocyte, donor1	11523-119I2	72.64	0.00	2.42
Hepatocyte, donor2	11603-120I1	95.88	0.00	1.08
Hepatocyte, donor3	11684-122I1	50.92	4.91	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	81.59	1.31	3.92
Intestinal epithelial cells (polarized), donor1	11246-116E4	69.39	2.62	1.57
Iris Pigment Epithelial Cells, donor1	11530-119I9	58.04	5.76	2.33
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	70.05	12.74	9.55
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	66.75	13.35	13.35
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	81.25	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	31.84	4.15	2.77
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	45.05	2.50	7.51
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	106.81	0.00	11.87
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	48.70	10.25	5.13
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	36.57	18.28	4.57
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	61.72	11.37	3.25
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	30.01	5.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	47.20	7.26	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	76.76	11.91	5.29
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	41.02	2.22	2.22
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	41.91	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	51.02	8.19	2.52
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	41.76	12.37	3.09
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	14.63	14.63	14.63
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	53.62	8.40	3.88
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	38.64	12.88	11.27
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	59.74	11.95	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	51.34	4.07	1.63
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	36.52	12.17	2.10
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	28.74	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	48.22	8.04	4.82
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	32.31	2.77	2.77
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	30.16	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	42.01	3.78	2.36
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	57.14	4.53	3.63
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	29.48	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	63.49	6.46	3.23
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	49.55	3.81	7.62
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	82.15	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	39.54	5.74	5.10
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	45.57	3.65	7.29
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	63.22	31.61	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	59.98	10.00	2.14
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	59.73	19.91	9.95
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	83.39	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	46.61	7.10	3.40
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	42.14	3.51	5.27
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	25.15	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	41.72	8.34	2.78
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	81.88	8.85	6.64
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	55.11	9.73	6.48
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	51.44	8.72	2.62
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	67.49	13.50	4.50
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	80.15	10.45	13.94
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	72.54	7.47	8.53
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	36.02	8.31	1.39
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	42.74	8.55	5.70
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	43.26	5.52	0.92
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	84.71	9.08	6.05
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	68.30	12.42	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	64.50	9.52	5.29
Keratinocyte - epidermal, donor1	11272-116H3	49.86	3.92	2.77
Keratinocyte - epidermal, donor2	11349-117G8	43.92	5.27	4.69
Keratinocyte - epidermal, donor3	11421-118F8	46.57	4.83	1.61
Keratinocyte - oral, donor1	11251-116E9	41.66	2.27	2.27
Keratocytes, donor1	11527-119I6	111.06	13.75	4.81
Keratocytes, donor2	11607-120I5	58.59	1.17	1.17
Keratocytes, donor3	11688-122I5	48.02	2.37	1.38
Krukenberg tumor cell line:HSKTC	10687-109F3	39.56	6.59	6.59
Lens Epithelial Cells, donor1	11529-119I8	65.80	2.16	6.47
Lens Epithelial Cells, donor2	11609-120I7	59.74	4.15	2.19
Lens Epithelial Cells, donor3	11690-122I7	47.73	3.43	2.83
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	53.48	3.91	4.15
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	48.00	4.74	4.19
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	50.06	3.15	5.04
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	60.22	4.30	4.30
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	58.94	7.56	5.99
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	53.15	5.28	5.93
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	58.69	3.28	3.28
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	60.68	5.31	5.56
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	47.57	4.22	5.21
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	58.54	5.54	4.35
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	50.60	5.62	5.04
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	66.47	4.44	5.37
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	52.96	6.27	3.48
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	50.81	5.96	3.58
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	63.45	5.08	4.40
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	47.73	5.54	8.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	67.65	4.36	4.36
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	62.03	4.21	4.21
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	58.25	3.95	4.61
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	58.87	6.44	3.51
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	66.71	5.73	6.72
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	71.77	3.39	2.91
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	57.09	4.31	5.39
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	49.20	5.75	5.60
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	59.10	4.67	6.22
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	52.98	6.49	4.82
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	50.22	5.41	4.36
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	66.72	5.50	5.50
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	52.68	4.70	3.57
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	51.21	3.92	6.36
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	61.06	4.36	3.88
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	45.32	5.62	3.31
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	50.18	4.96	2.97
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	62.94	4.44	2.59
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	48.92	4.94	3.71
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	51.01	4.54	4.81
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	55.97	5.47	5.15
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	50.52	2.13	3.04
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	49.41	3.36	4.76
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	52.27	6.04	4.27
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	60.11	6.79	3.39
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	58.82	6.54	5.60
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	62.67	4.30	3.94
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	46.06	4.90	2.29
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	62.39	5.65	6.83
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	50.00	3.59	5.07
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	53.79	2.82	2.56
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	46.84	7.46	5.37
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	56.65	4.53	4.53
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	73.64	3.84	3.84
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	75.71	5.94	2.97
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	79.55	6.35	9.31
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	71.74	6.33	10.55
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	90.59	14.01	6.54
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	76.26	9.27	8.24
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	83.26	14.27	3.57
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	78.72	6.11	4.98
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	77.36	2.91	5.53
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	70.23	5.85	4.05
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	65.71	8.94	4.74
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	82.16	9.24	7.19
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	71.28	4.59	5.65
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	83.29	6.00	4.66
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	80.48	4.08	7.13
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	55.76	5.60	4.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	82.00	4.72	6.80
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	91.42	9.82	12.27
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	85.62	8.97	4.89
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	76.84	6.25	4.16
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	74.55	5.04	6.73
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	75.21	3.09	5.15
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	73.45	10.16	6.39
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	83.70	5.98	4.78
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	61.41	7.19	5.53
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	70.70	6.72	4.60
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	76.34	7.01	5.90
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	87.50	3.45	2.30
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	84.43	8.44	8.44
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	79.82	7.36	7.36
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	93.53	10.67	6.56
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	81.34	7.23	5.87
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	86.90	7.90	6.46
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	82.91	8.22	4.48
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	67.63	4.83	4.46
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	78.83	7.75	3.88
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	64.22	9.42	3.43
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	87.63	8.33	8.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	77.83	9.65	7.24
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	83.90	5.69	3.55
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	73.90	8.59	6.87
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	80.51	4.29	9.12
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	65.32	8.08	6.06
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	77.04	6.30	5.56
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	87.22	10.47	6.98
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	100.49	12.69	6.35
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	74.03	6.00	5.20
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	58.88	5.81	10.18
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	65.15	13.80	4.60
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	72.02	8.88	8.39
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	63.04	13.17	6.59
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	79.45	10.06	7.54
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	73.90	6.76	6.31
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	63.68	5.16	3.44
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	62.79	10.24	6.23
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	74.69	5.87	3.91
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	68.61	5.94	4.62
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	74.73	5.71	7.78
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	68.70	7.44	3.50
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	65.97	7.27	7.83
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	65.80	6.18	4.86
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	65.96	9.26	5.01
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	69.37	9.62	4.56
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	74.02	5.77	4.33
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	75.53	4.37	5.57
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	53.47	8.51	10.33
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	71.94	3.46	3.46
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	73.34	8.36	6.08
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	75.91	3.61	9.30
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	62.28	5.44	5.44
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	71.62	8.24	5.07
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	62.90	6.93	6.93
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	62.06	4.02	10.34
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	72.51	9.26	7.20
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	78.52	4.24	4.24
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	65.83	8.51	4.54
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	72.80	9.57	4.16
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	95.53	7.83	7.83
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	68.48	5.01	6.26
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	83.17	9.76	9.76
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	88.98	6.02	8.70
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	75.38	5.35	8.02
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	71.93	8.08	9.70
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	73.42	5.51	7.34
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	79.13	7.11	8.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	100.87	15.96	9.69
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	98.93	5.37	14.57
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	72.23	7.66	6.02
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	67.26	9.80	7.57
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	76.17	7.54	5.72
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	99.47	5.97	5.30
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	128.87	6.24	6.24
Macrophage - monocyte derived, donor1	11232-116C8	68.60	1.37	0.46
Macrophage - monocyte derived, donor2	11313-117C8	38.90	2.57	0.73
Macrophage - monocyte derived, donor3	11389-118C3	63.44	1.97	0.92
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	77.00	10.09	4.78
Mallassez-derived cells, donor2	11929-125I3	67.50	5.23	6.81
Mallassez-derived cells, donor3	11930-125I4	69.49	8.48	4.73
Mammary Epithelial Cell, donor1	11273-116H4	49.42	7.07	2.09
Mammary Epithelial Cell, donor2	11350-117G9	39.09	4.34	1.45
Mammary Epithelial Cell, donor3	11422-118F9	36.42	6.98	1.75
Mast cell - stimulated, donor1	11487-119E2	8.14	0.00	0.00
Mast cell, donor1	11563-120D6	24.44	0.32	0.76
Mast cell, donor2	11565-120D8	30.91	0.00	0.89
Mast cell, donor3	11566-120D9	38.50	0.68	1.13
Mast cell, donor4	11567-120E1	26.42	0.00	0.89
Mast cell, expanded and stimulated, donor5	11940-126A5	42.80	2.11	1.89
Mast cell, expanded and stimulated, donor8	11942-126A7	41.44	1.75	2.92
Mast cell, expanded, donor5	11939-126A4	53.92	0.57	1.03
Mast cell, expanded, donor8	11941-126A6	32.64	0.67	0.84
Melanocyte - dark, donor1	11502-119F8	41.09	2.49	3.38
Melanocyte - dark, donor2	11582-120F7	69.22	3.46	3.46
Melanocyte - dark, donor3	11663-122F7	57.81	5.51	1.67
Melanocyte - light, donor1	11274-116H5	33.15	1.41	2.12
Melanocyte - light, donor2	11351-117H1	45.04	2.05	4.09
Melanocyte - light, donor3	11423-118G1	33.82	4.34	0.87
Melanocyte, donor1 (MC+1)	12641-134G4	60.29	4.48	2.39
Melanocyte, donor2 (MC+2)	12739-135I3	96.55	2.96	2.15
Melanocyte, donor3 (MC+3)	12837-137B2	62.95	2.95	2.41
Meningeal Cells, donor1	11493-119E8	56.57	3.97	2.85
Meningeal Cells, donor2	11573-120E7	42.25	1.76	2.64
Meningeal Cells, donor3	11654-122E7	51.84	5.71	1.71
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	71.29	6.27	3.42
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	36.03	2.21	2.42
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	102.50	3.94	3.94
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	105.96	11.77	9.16
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	75.35	5.02	2.87
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	38.97	0.64	2.33
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	31.16	1.51	3.02
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	84.17	9.01	2.86
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	60.64	7.31	2.19
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	79.39	6.75	5.32
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	52.77	3.05	3.60
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	58.73	3.35	2.23
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	45.66	1.45	1.58
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	46.88	1.19	4.15
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	77.07	0.00	2.34
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	69.16	3.20	3.20
Mesenchymal stem cells - adipose, donor0	11217-116B2	50.33	6.03	2.84
Mesenchymal stem cells - hepatic, donor0	11218-116B3	34.71	1.56	0.63
Mesenchymal stem cells - umbilical, donor0	11214-116A8	69.67	6.53	4.35
Mesothelial Cells, donor1	11247-116E5	59.40	3.98	2.39
Mesothelial Cells, donor2	12156-128G5	49.55	4.50	6.01
Mesothelial Cells, donor3	11402-118D7	34.61	3.25	1.88
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	14.85	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	46.79	1.23	1.48
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	58.01	2.36	2.36
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	13.83	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	47.73	2.17	0.62
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	46.88	1.66	0.83
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	16.21	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	55.06	2.25	0.25
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	39.57	2.33	0.93
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	44.50	1.83	1.83
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	52.66	3.56	1.98
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	17.10	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	58.41	5.31	2.65
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	68.77	4.56	2.28
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	13.16	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	52.63	2.55	0.85
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	14.73	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	27.12	2.38	0.89
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	20.12	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	50.43	2.51	1.25
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	40.88	3.09	1.19
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	21.01	1.11	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	48.12	2.53	0.69
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	40.60	1.68	0.42
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	43.62	2.04	1.02
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	55.57	1.07	1.07
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	24.67	1.33	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	10.32	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	41.61	1.31	0.66
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	23.83	1.01	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	11.60	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	28.54	0.82	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	33.23	2.06	0.88
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	9.81	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	61.03	4.32	1.92
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	53.63	2.40	2.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	21.94	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	55.56	2.00	0.50
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	188.63	26.95	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	12.23	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	61.31	3.50	2.19
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	17.66	1.10	1.10
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	12.81	0.00	0.64
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	57.02	2.73	1.98
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	22.27	1.39	0.70
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	11.05	0.00	2.21
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	55.04	3.42	1.37
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	17.94	2.19	0.44
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	13.49	1.78	0.71
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	65.09	5.05	3.09
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	33.67	2.49	2.08
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	17.48	0.58	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	42.23	2.11	0.90
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	49.25	1.67	1.25
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	21.66	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	32.32	1.85	0.92
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	43.82	2.28	0.57
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	19.90	0.97	0.14
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	46.91	2.85	0.78
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	39.89	2.57	0.43
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	13.97	0.64	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	26.16	1.07	0.27
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	63.76	2.69	2.69
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	24.30	0.71	0.71
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	57.01	4.46	0.96
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	60.37	3.54	0.88
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	31.47	1.14	0.38
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	50.85	2.56	1.14
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	68.58	3.44	2.21
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	31.28	0.65	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	40.28	1.18	1.18
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	73.23	4.32	1.15
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	23.90	0.41	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	36.03	1.19	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	180.81	3.77	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	90.89	5.35	1.78
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	78.86	1.31	0.33
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	83.10	1.05	1.05
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	64.64	1.38	0.20
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	53.09	1.86	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	79.61	2.25	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	50.61	1.86	0.53
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	60.06	0.68	0.45
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	64.83	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	69.25	0.73	0.37
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	42.00	1.56	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	101.01	1.60	1.60
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	100.46	3.86	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	71.71	2.02	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	59.03	0.84	1.26
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	84.44	1.36	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	99.82	0.64	0.64
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	114.19	0.00	0.81
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	63.44	4.53	1.51
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	45.68	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	52.20	6.52	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	19.01	9.50	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	37.65	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	59.89	3.88	2.80
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	40.24	0.00	1.57
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	37.38	2.00	0.67
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	27.96	2.09	1.67
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	62.18	3.23	2.09
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	41.49	4.79	1.60
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	22.44	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	16.54	1.84	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	35.99	1.26	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	43.00	2.32	0.70
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	24.32	2.16	0.54
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	23.34	0.84	1.05
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	55.67	0.00	11.13
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	44.67	4.96	1.99
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	46.01	1.08	1.62
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	44.20	0.68	1.81
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	25.31	0.98	0.82
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	33.90	1.64	1.28
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	31.83	2.65	1.06
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	23.41	0.00	1.20
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	59.40	0.00	2.95
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	26.67	1.14	1.79
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	23.11	0.53	1.76
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	35.16	2.81	2.11
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	31.72	0.92	0.92
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	36.95	1.29	1.29
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	43.46	1.03	2.76
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	10.11	5.06	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	18.49	0.45	0.22
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	24.98	0.42	1.69
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	32.28	0.47	1.42
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	40.35	3.43	2.15
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	18.06	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	27.99	1.00	1.33
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	17.58	0.45	1.35
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	32.54	1.59	1.59
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	39.93	0.93	3.71
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	51.08	3.78	1.89
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	19.88	2.61	1.30
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	17.43	0.87	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	20.35	1.81	1.81
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	31.75	2.65	4.41
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	31.25	1.99	0.66
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	38.69	1.49	3.47
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	16.08	2.30	1.15
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	72.28	2.12	3.33
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	29.40	1.55	2.43
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	27.11	2.03	2.03
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	10.22	5.11	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	33.53	0.61	0.61
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	22.03	1.89	1.26
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	23.30	1.21	0.91
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	36.39	2.37	3.16
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	52.15	3.40	1.13
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	45.52	0.00	0.00
Myoblast, donor1	11241-116D8	57.39	4.60	3.73
Myoblast, donor2	11322-117D8	47.56	3.84	2.30
Myoblast, donor3	11398-118D3	44.56	3.03	2.19
NK T cell leukemia cell line:KHYG-1	10777-110G3	49.47	1.17	0.58
Natural Killer Cells, donor1	11230-116C6	40.90	0.31	1.54
Natural Killer Cells, donor2	11311-117C6	31.06	0.60	0.90
Natural Killer Cells, donor3	11387-118C1	28.34	0.37	0.92
Neural stem cells, donor1	11275-116H6	38.47	2.18	2.90
Neural stem cells, donor2	11352-117H2	25.03	0.00	1.93
Neurons, donor1	11494-119E9	77.38	3.41	4.55
Neurons, donor2	11574-120E8	47.34	1.54	1.32
Neurons, donor3	11655-122E8	39.46	4.11	3.29
Neutrophils, donor1	11233-116C9	65.89	4.64	0.93
Neutrophils, donor2	11314-117C9	66.67	5.80	2.90
Neutrophils, donor3	11390-118C4	61.70	5.50	1.22
Nucleus Pulposus Cell, donor1	11252-116F1	44.29	2.26	2.02
Nucleus Pulposus Cell, donor2	11409-118E5	66.10	2.28	2.60
Nucleus Pulposus Cell, donor3	11462-119B4	55.55	2.01	3.81
Olfactory epithelial cells, donor1	11933-125I7	29.46	2.34	3.44
Olfactory epithelial cells, donor2	11934-125I8	45.16	2.89	2.17
Olfactory epithelial cells, donor3	11935-125I9	33.14	2.50	2.04
Olfactory epithelial cells, donor4	11936-126A1	36.91	1.85	1.85
Oligodendrocyte - precursors, donor1	11496-119F2	62.59	4.81	2.41
Osteoblast - differentiated, donor1	11276-116H7	45.94	2.77	3.83
Osteoblast - differentiated, donor2	11353-117H3	59.44	6.86	4.57
Osteoblast - differentiated, donor3	11425-118G3	58.35	3.72	2.48
Osteoblast, donor1	11277-116H8	87.36	7.04	2.93
Osteoblast, donor2	11354-117H4	48.46	6.32	4.92
Osteoblast, donor3	11426-118G4	62.56	7.82	3.20
Pancreatic stromal cells, donor1	11249-116E7	50.37	3.20	2.02
Pericytes, donor1	11491-119E6	70.65	3.34	4.56
Pericytes, donor2	11571-120E5	58.18	3.17	5.89
Pericytes, donor3	11652-122E5	64.70	6.31	3.26
Perineurial Cells, donor1	11499-119F5	53.91	5.88	3.16
Perineurial Cells, donor2	11579-120F4	55.02	3.59	2.12
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	44.94	0.00	1.27
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	49.71	0.24	0.73
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	32.48	0.26	0.26
Placental Epithelial Cells, donor1	11278-116H9	82.27	5.74	3.83
Placental Epithelial Cells, donor2	11355-117H5	96.47	6.65	4.44
Placental Epithelial Cells, donor3	11427-118G5	67.34	3.34	3.73
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	56.33	6.96	5.70
Preadipocyte - breast, donor1	11467-119B9	34.14	2.06	3.00
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	20.49	1.70	1.04
Preadipocyte - breast, donor2	11328-117E5	40.30	3.15	3.60
Preadipocyte - omental, donor1	11468-119C1	38.68	2.56	2.34
Preadipocyte - omental, donor2	11329-117E6	29.68	2.18	3.06
Preadipocyte - omental, donor3	11403-118D8	41.97	3.87	2.01
Preadipocyte - perirenal, donor1	11469-119C2	60.04	1.97	1.97
Preadipocyte - subcutaneous, donor1	11279-116I1	59.27	5.22	2.46
Preadipocyte - subcutaneous, donor2	11356-117H6	47.99	5.67	3.36
Preadipocyte - subcutaneous, donor3	11428-118G6	58.07	4.43	3.24
Preadipocyte - visceral, donor1	11280-116I2	54.86	4.66	1.96
Preadipocyte - visceral, donor2	11357-117H7	50.62	4.14	3.68
Preadipocyte - visceral, donor3	11429-118G7	54.54	3.55	1.99
Prostate Epithelial Cells (polarized), donor1	11253-116F2	45.10	2.87	2.56
Prostate Epithelial Cells, donor2	11331-117E8	49.02	6.50	3.79
Prostate Epithelial Cells, donor3	11404-118D9	23.82	3.98	2.08
Prostate Stromal Cells, donor1	11254-116F3	56.72	5.35	2.51
Prostate Stromal Cells, donor2	11332-117E9	60.24	4.12	2.15
Prostate Stromal Cells, donor3	11405-118E1	45.57	4.38	1.88
Renal Cortical Epithelial Cells, donor1	11516-119H4	53.29	8.39	5.47
Renal Cortical Epithelial Cells, donor2	11596-120H3	48.80	6.24	5.41
Renal Epithelial Cells, donor1	11517-119H5	100.94	12.17	7.61
Renal Epithelial Cells, donor2	11597-120H4	86.78	4.98	5.69
Renal Epithelial Cells, donor3	11678-122H4	51.77	5.50	4.76
Renal Glomerular Endothelial Cells, donor1	11514-119H2	46.30	1.36	3.40
Renal Glomerular Endothelial Cells, donor2	11594-120H1	55.12	2.56	1.89
Renal Glomerular Endothelial Cells, donor3	11675-122H1	54.61	4.66	4.22
Renal Glomerular Endothelial Cells, donor4	11783-124B1	63.88	4.66	4.66
Renal Mesangial Cells, donor1	11518-119H6	70.65	5.72	3.52
Renal Mesangial Cells, donor2	11598-120H5	58.31	5.64	5.64
Renal Mesangial Cells, donor3	11679-122H5	73.79	5.27	3.05
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	60.13	9.39	7.25
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	51.02	17.29	6.75
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	59.20	9.26	5.98
Retinal Pigment Epithelial Cells, donor0	11215-116A9	52.63	5.44	4.15
Retinal Pigment Epithelial Cells, donor1	11528-119I7	38.94	2.56	2.27
Retinal Pigment Epithelial Cells, donor2	11608-120I6	61.75	8.23	1.03
Retinal Pigment Epithelial Cells, donor3	11689-122I6	68.75	4.01	3.51
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	45.97	2.81	1.74
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	29.48	0.89	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	47.88	2.75	0.55
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	18.56	0.58	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	16.25	0.52	0.65
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	22.94	0.60	0.50
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	28.33	1.67	0.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	18.11	0.87	0.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	26.46	1.28	1.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	29.82	1.85	1.62
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	13.96	0.96	0.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	16.94	0.76	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	31.36	1.25	0.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	18.22	0.72	0.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	25.76	1.07	1.07
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	30.76	0.89	1.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	14.34	0.57	0.76
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	18.54	1.40	0.75
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	25.74	1.32	0.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	16.85	0.66	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	17.42	0.88	0.78
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	26.35	1.34	1.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	14.84	0.43	0.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	18.22	0.84	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	20.68	1.20	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	14.04	0.36	1.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	16.43	1.10	0.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	26.46	1.88	1.07
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	20.76	1.65	1.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	21.23	0.79	0.79
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	27.36	0.94	0.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	23.02	0.62	0.62
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	23.89	1.55	1.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	20.47	1.67	0.84
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	22.48	1.35	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	13.45	0.85	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	21.21	0.77	0.77
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	20.12	0.69	1.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	14.27	1.23	0.96
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	22.16	0.99	1.64
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	17.55	0.51	0.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	23.53	0.74	0.59
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	24.26	1.60	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	16.73	0.83	0.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	22.86	0.95	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	23.18	1.61	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	20.25	0.85	0.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	30.74	1.05	0.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	22.36	1.21	1.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	24.35	0.86	0.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	28.24	1.60	0.87
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	58.41	1.83	4.26
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	25.62	0.00	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	37.09	1.81	0.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	41.64	1.80	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	35.66	0.47	0.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	22.63	1.92	0.64
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	18.03	1.80	0.00
Schwann Cells, donor1	11498-119F4	75.04	7.52	4.51
Schwann Cells, donor2	11578-120F3	44.23	10.21	3.40
Schwann Cells, donor3	11659-122F3	74.05	4.16	3.94
Sebocyte, donor1	11220-116B5	30.13	3.83	3.29
Sebocyte, donor2	11301-117B5	37.68	3.22	2.30
Sebocyte, donor3	11378-118B1	31.33	3.50	0.41
Sertoli Cells, donor1	11255-116F4	43.07	3.31	0.00
Sertoli Cells, donor2	11333-117F1	36.72	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	66.60	4.75	3.96
Skeletal Muscle Cells, donor2	11358-117H8	57.83	2.89	4.34
Skeletal Muscle Cells, donor3	11430-118G8	101.16	11.70	5.02
Skeletal Muscle Cells, donor4	11451-119A2	55.77	3.93	3.61
Skeletal Muscle Cells, donor5	11455-119A6	49.20	4.16	2.97
Skeletal Muscle Cells, donor6	11459-119B1	42.17	5.54	4.46
Skeletal Muscle Satellite Cells, donor1	11240-116D7	63.76	3.78	3.28
Skeletal Muscle Satellite Cells, donor2	11321-117D7	52.79	3.85	3.42
Skeletal Muscle Satellite Cells, donor3	11397-118D2	49.01	5.16	2.48
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	49.71	5.06	3.45
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	75.27	9.41	2.90
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	61.92	3.44	3.03
Skin - palm, donor1	10286-104F7	13.43	0.00	2.69
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	62.56	6.63	4.32
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	28.63	4.91	1.64
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	47.52	4.41	2.73
Small Airway Epithelial Cells, donor1	11256-116F5	47.54	6.81	3.61
Small Airway Epithelial Cells, donor2	11334-117F2	34.88	3.38	1.27
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	23.68	2.96	1.27
Small Airway Epithelial Cells, donor3	11406-118E2	27.51	3.67	1.65
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	23.76	2.47	4.94
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	62.47	4.45	2.45
Smooth Muscle Cells - Aortic, donor0	11210-116A4	44.09	4.11	2.94
Smooth Muscle Cells - Aortic, donor1	11283-116I5	52.37	2.65	0.88
Smooth Muscle Cells - Aortic, donor2	11360-117I1	69.70	7.09	1.58
Smooth Muscle Cells - Aortic, donor3	11432-118H1	67.99	2.32	6.18
Smooth Muscle Cells - Bladder, donor1	11519-119H7	40.03	1.00	2.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	52.83	8.38	5.46
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	53.64	3.32	4.88
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	58.51	3.46	3.71
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	57.63	6.51	3.58
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	44.30	2.07	1.18
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	36.30	2.85	1.14
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	61.17	5.53	3.42
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	39.88	2.44	1.52
Smooth Muscle Cells - Carotid, donor1	11285-116I7	52.03	3.28	3.03
Smooth Muscle Cells - Carotid, donor2	11362-117I3	73.45	0.00	6.12
Smooth Muscle Cells - Carotid, donor3	11434-118H3	86.31	4.29	6.68
Smooth Muscle Cells - Colonic, donor1	11239-116D6	40.70	4.42	2.51
Smooth Muscle Cells - Colonic, donor2	11320-117D6	50.15	3.87	1.72
Smooth Muscle Cells - Colonic, donor3	11396-118D1	48.70	3.46	1.47
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	57.54	6.03	3.09
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	84.07	3.23	5.39
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	57.98	3.89	2.99
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	80.57	6.15	3.41
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	47.04	1.65	1.81
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	43.07	3.12	1.81
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	80.78	3.87	1.82
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	68.23	7.25	4.23
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	49.81	7.15	3.18
Smooth Muscle Cells - Prostate, donor1	11257-116F6	43.94	3.46	2.00
Smooth Muscle Cells - Prostate, donor2	11335-117F3	32.81	3.63	1.88
Smooth Muscle Cells - Prostate, donor3	11465-119B7	40.84	0.76	1.78
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	52.47	4.67	2.26
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	61.51	3.00	1.50
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	32.31	2.58	1.29
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	66.97	7.44	2.79
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	61.60	7.07	3.03
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	65.19	3.13	3.45
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	45.72	4.13	1.77
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	36.16	3.75	2.00
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	45.31	0.00	1.40
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	51.23	3.74	2.88
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	63.99	5.86	3.82
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	50.96	2.82	2.07
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	45.56	5.31	3.49
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	44.16	4.36	2.77
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	86.67	3.33	2.38
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	50.64	2.45	3.43
Smooth Muscle Cells - Uterine, donor1	11258-116F7	32.26	1.77	1.99
Smooth Muscle Cells - Uterine, donor3	11466-119B8	59.39	8.48	4.10
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	47.23	2.14	1.17
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	34.38	1.06	1.32
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	56.16	2.98	1.12
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	42.76	4.67	3.59
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	50.53	4.26	1.99
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	67.35	3.15	4.73
Smooth muscle cells - airway, control, donor1	11966-126D4	42.41	2.03	2.03
Smooth muscle cells - airway, control, donor2	11967-126D5	47.92	0.80	1.60
Smooth muscle cells - airway, control, donor3	11968-126D6	54.76	2.93	1.67
Smooth muscle cells - airway, control, donor4	11969-126D7	49.50	2.29	4.13
Synoviocyte, donor1	11291-117A4	53.02	3.20	3.70
Synoviocyte, donor2	11368-117I9	57.66	1.51	3.18
Synoviocyte, donor3	11440-118H9	46.25	3.35	2.46
Trabecular Meshwork Cells, donor1	11532-120A2	56.46	2.86	1.43
Trabecular Meshwork Cells, donor2	11612-122A1	89.19	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	65.30	6.25	3.70
Tracheal Epithelial Cells, donor1	11292-117A5	36.63	3.37	1.29
Tracheal Epithelial Cells, donor2	11369-118A1	51.41	6.57	4.64
Tracheal Epithelial Cells, donor3	11441-118I1	54.40	4.01	1.72
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	50.81	2.58	1.23
Urethra, donor2	10319-105A4	14.39	1.80	0.00
Urothelial Cells, donor1	11520-119H8	73.85	8.77	4.78
Urothelial Cells, donor2	11600-120H7	48.87	4.81	3.20
Urothelial Cells, donor3	11681-122H7	53.63	4.35	3.44
Urothelial cells, donor0	11216-116B1	44.13	3.12	2.90
Whole blood (ribopure), donor090309, donation1	12179-129A1	84.53	3.56	0.89
Whole blood (ribopure), donor090309, donation2	12180-129A2	104.36	7.15	4.29
Whole blood (ribopure), donor090309, donation3	12181-129A3	71.87	2.05	2.05
Whole blood (ribopure), donor090325, donation1	12176-128I7	51.65	2.07	1.72
Whole blood (ribopure), donor090325, donation2	12177-128I8	77.28	5.81	2.32
Whole blood (ribopure), donor090612, donation1	12182-129A4	76.01	6.25	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	89.03	0.92	2.75
Whole blood (ribopure), donor090612, donation3	12184-129A6	80.34	4.56	1.83
Wilms' tumor cell line:G-401	10809-111A8	50.21	2.59	1.23
Wilms' tumor cell line:HFWT	10597-108E3	10.56	0.00	0.88
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	36.03	2.79	0.56
achilles tendon, donor2	10292-104G4	24.80	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	44.87	5.86	3.82
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	52.47	0.70	1.63
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	23.03	4.39	2.85
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	64.76	3.27	2.72
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	42.72	1.97	1.41
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	74.23	3.17	2.11
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	40.29	1.36	1.36
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	54.64	2.64	0.44
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	61.66	1.63	0.82
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	77.66	1.16	0.00
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	44.90	2.21	1.66
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	42.91	0.00	3.90
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	45.08	2.09	2.79
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	86.99	6.21	5.70
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	44.42	3.21	1.75
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	37.18	1.39	0.93
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	79.78	3.29	2.47
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	72.13	2.76	2.15
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	64.86	5.97	2.56
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	65.81	4.55	0.91
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	81.12	6.50	2.89
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	34.08	1.78	0.67
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	29.02	2.33	1.67
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	11.15	1.86	1.86
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	37.67	5.27	2.26
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	30.53	0.44	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	54.36	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	53.69	0.94	0.47
adipose tissue, adult, pool1	10010-101C1	28.70	1.09	0.47
adipose, donor1	10184-103D4	70.37	5.28	3.52
adipose, donor2	10185-103D5	58.80	5.68	4.06
adipose, donor3	10186-103D6	60.72	7.08	4.36
adipose, donor4	10187-103D7	50.27	3.47	2.60
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	30.30	1.74	1.74
adrenal gland, adult, pool1	10081-102A9	40.01	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	25.48	1.33	0.80
alveolar cell carcinoma cell line:SW 1573	10708-109H6	35.37	3.93	2.50
amniotic membrane cells, donor1	12235-129G3	61.67	3.01	3.25
amniotic membrane cells, donor2	12236-129G4	95.68	4.40	3.04
amniotic membrane cells, donor3	12237-129G5	39.77	1.18	0.88
amygdala - adult, donor10196	10167-103B5	36.76	4.74	5.93
amygdala, adult, donor10252	10151-102I7	41.57	2.84	1.42
amygdala, newborn, donor10223	10360-105E9	39.70	1.94	1.29
anaplastic carcinoma cell line:8305C	10428-106D5	39.34	1.15	1.53
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	66.19	6.84	3.75
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	38.75	2.00	1.67
aorta, adult, pool1	10052-101G7	42.56	1.96	1.57
appendix, adult	10189-103D9	38.42	2.72	1.16
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	50.56	2.75	3.44
artery, adult	10190-103E1	67.93	0.00	1.36
astrocytoma cell line:TM-31	10425-106D2	50.56	1.45	1.01
b cell line:RPMI1788	10427-106D4	18.89	5.20	3.27
basal cell carcinoma cell line:TE 354.T	10702-109G9	52.16	3.61	3.61
bile duct carcinoma cell line:HuCCT1	10432-106D9	29.17	5.16	3.37
bile duct carcinoma cell line:TFK-1	10496-107C1	39.00	3.35	1.67
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	88.92	3.91	3.36
bladder, adult, pool1	10011-101C2	28.14	1.96	1.30
blood, adult, pool1	10053-101G8	31.00	2.21	2.21
bone marrow stromal cell line:StromaNKtert	10686-109F2	15.41	0.00	0.00
bone marrow, adult	10192-103E3	59.38	3.37	2.02
brain, adult, donor1	10084-102B3	43.05	2.05	4.10
brain, adult, pool1	10012-101C3	44.43	2.56	1.89
brain, fetal, pool1	10085-102B4	61.44	5.34	2.67
breast carcinoma cell line:MCF7	10482-107A5	35.02	4.96	3.63
breast carcinoma cell line:MDA-MB-453	10419-106C5	57.04	2.00	0.87
breast, adult, donor1	10080-102A8	26.52	1.89	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	45.61	2.41	0.64
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	47.00	3.40	0.93
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	150.79	20.26	20.49
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	72.14	5.57	3.39
carcinoid cell line:NCI-H1770	10703-109H1	47.02	4.70	3.29
carcinoid cell line:NCI-H727	10735-110B6	19.69	2.52	0.98
carcinoid cell line:SK-PN-DW	10719-109I8	31.37	2.54	1.90
carcinosarcoma cell line:JHUCS-1	10642-109A3	40.19	3.46	6.12
caudate nucleus - adult, donor10196	10177-103C6	59.87	0.00	2.30
caudate nucleus, adult, donor10252	10164-103B2	56.56	2.01	2.51
caudate nucleus, adult, donor10258	10379-105H1	71.06	4.58	12.23
caudate nucleus, newborn, donor10223	10354-105E3	69.95	4.39	2.93
cerebellum - adult, donor10196	10173-103C2	34.96	11.65	14.57
cerebellum, adult, donor10252	10166-103B4	29.25	1.07	1.49
cerebellum, adult, pool1	10083-102B2	24.84	2.07	2.76
cerebellum, newborn, donor10223	10357-105E6	74.73	7.47	9.13
cerebral meninges, adult	10188-103D8	53.20	2.02	2.02
cerebrospinal fluid, donor2	10294-104G6	22.66	0.73	0.73
cervical cancer cell line:D98-AH2	10552-107I3	29.48	5.18	2.16
cervical cancer cell line:ME-180	10553-107I4	54.85	1.82	0.99
cervix, adult, pool1	10013-101C4	42.94	1.89	1.05
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	65.77	3.07	2.23
chondrosarcoma cell line:SW 1353	10700-109G7	9.14	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	45.61	3.23	2.86
choriocarcinoma cell line:SCH	10785-110H2	51.75	5.67	3.08
choriocarcinoma cell line:T3M-3	10618-108G6	13.99	4.27	5.22
chorionic membrane cells, donor1	12238-129G6	59.83	5.41	3.42
chorionic membrane cells, donor2	12239-129G7	45.44	4.57	1.19
chorionic membrane cells, donor3	12240-129G8	32.42	2.20	2.20
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	84.82	1.01	4.04
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	72.23	3.27	2.11
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	35.48	1.27	0.63
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	25.17	3.34	3.08
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	31.20	4.60	1.69
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	28.30	4.48	2.65
chronic myelogenous leukemia cell line:K562	10454-106G4	44.17	7.36	2.06
chronic myelogenous leukemia cell line:KU812	10409-106B4	57.08	2.09	0.00
clear cell carcinoma cell line:JHOC-5	10638-108I8	120.46	11.20	8.91
clear cell carcinoma cell line:TEN	10636-108I6	77.04	5.73	6.07
colon carcinoma cell line:CACO-2	10513-107D9	45.58	2.93	1.28
colon carcinoma cell line:COLO-320	10420-106C6	37.25	2.66	1.14
colon, adult, donor1	10082-102B1	59.50	4.76	0.00
colon, adult, pool1	10014-101C5	54.87	2.23	1.41
colon, fetal, donor1	10070-101I7	27.81	1.85	0.00
common myeloid progenitor CMP, donor1	12130-128D6	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	100.15	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	44.62	4.25	7.22
cord blood derived cell line:COBL-a 24h infection	10453-106G3	42.26	8.75	5.13
cord blood derived cell line:COBL-a untreated	10449-106F8	37.09	7.90	5.64
corpus callosum, adult, pool1	10042-101F6	93.43	4.75	3.76
cruciate ligament, donor2	10295-104G7	24.31	0.00	3.24
diaphragm, fetal, donor1	10069-101I6	30.50	0.00	1.61
diencephalon, adult	10193-103E4	50.16	3.60	3.60
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	29.85	2.98	1.38
ductal cell carcinoma cell line:KLM-1	10438-106E6	48.47	1.03	1.03
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	39.48	6.02	2.65
ductus deferens, adult	10196-103E7	66.78	2.49	0.50
duodenum, fetal, donor1, tech_rep1	10071-101I8	38.89	1.44	1.44
duodenum, fetal, donor1, tech_rep2	10071-101I8	70.62	0.74	0.74
dura mater, adult, donor1	10041-101F5	45.42	1.32	1.16
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	64.18	13.99	6.66
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	48.72	8.17	5.45
embryonic pancreas cell line:1B2C6	10604-108F1	28.98	3.08	1.85
embryonic pancreas cell line:1C3D3	10605-108F2	30.27	2.12	1.51
embryonic pancreas cell line:1C3IKEI	10606-108F3	31.18	1.85	1.85
embryonic pancreas cell line:2C6	10603-108E9	22.33	1.31	1.31
endometrial carcinoma cell line:OMC-2	10497-107C2	122.35	7.71	1.34
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	59.45	1.63	2.17
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	111.44	13.83	9.33
epidermoid carcinoma cell line:A431	10426-106D3	39.24	1.11	0.56
epidermoid carcinoma cell line:Ca Ski	10431-106D8	62.36	8.69	2.86
epididymis, adult	10197-103E8	74.31	2.93	1.47
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	57.13	3.90	1.24
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	29.49	3.15	0.79
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	59.89	4.59	3.01
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	45.37	2.66	0.98
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	58.37	4.15	1.34
esophagus, adult, pool1	10015-101C6	48.84	1.70	1.27
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	52.72	7.51	4.01
eye - muscle inferior rectus, donor1	10272-104E2	19.32	0.00	2.41
eye - muscle lateral, donor2	10298-104H1	23.15	0.00	0.00
eye - muscle medial, donor2	10299-104H2	19.35	0.00	0.00
eye - muscle superior, donor2	10297-104G9	21.78	0.00	1.15
eye - vitreous humor, donor1	10268-104D7	10.20	0.00	0.00
eye, fetal, donor1	10054-101G9	46.52	4.32	1.78
fibrosarcoma cell line:HT-1080	10758-110E2	33.59	1.67	1.28
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	37.04	1.66	2.61
frontal lobe, adult, pool1	10040-101F4	44.38	3.66	2.53
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	86.77	1.80	1.50
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	58.98	6.03	3.93
gall bladder, adult	10198-103E9	46.60	1.45	1.21
gamma delta positive T cells, donor1	11937-126A2	95.56	2.15	2.68
gamma delta positive T cells, donor2	11938-126A3	67.98	3.36	2.99
gastric adenocarcinoma cell line:MKN1	10614-108G2	122.72	7.18	8.03
gastric adenocarcinoma cell line:MKN45	10612-108F9	84.14	2.32	1.55
gastric cancer cell line:AZ521	10549-107H9	45.09	5.57	3.93
gastric cancer cell line:GSS	10560-108A2	79.62	11.90	21.05
gastrointestinal carcinoma cell line:ECC12	10615-108G3	107.15	2.51	5.71
giant cell carcinoma cell line:LU65	10487-107B1	39.81	5.28	2.29
giant cell carcinoma cell line:Lu99B	10433-106E1	16.52	4.48	3.36
glassy cell carcinoma cell line:HOKUG	10688-109F4	62.11	2.49	1.25
glioblastoma cell line:A172, tech_rep1	10444-106F3	25.97	2.96	1.69
glioblastoma cell line:A172, tech_rep2	10444-106F3	24.72	4.49	2.39
glioblastoma cell line:T98G	10485-107A8	50.99	3.31	1.55
glioma cell line:GI-1	10413-106B8	24.31	3.22	3.81
globus pallidus - adult, donor10196	10175-103C4	48.84	1.46	4.37
globus pallidus, adult, donor10252	10161-103A8	64.93	1.95	1.22
globus pallidus, adult, donor10258	10367-105F7	65.72	1.37	6.85
globus pallidus, newborn, donor10223	10364-105F4	51.69	2.13	5.33
granulocyte macrophage progenitor, donor1	12131-128D7	48.94	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	131.14	10.93	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	277.01	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	24.64	1.28	0.00
hIPS +CCl2, biol_rep1	14383-156B9	84.94	2.75	2.30
hIPS +CCl2, biol_rep2	14384-156C1	69.05	1.37	0.00
hIPS +CCl2, biol_rep3	14385-156C2	78.58	3.22	1.29
hIPS, biol_rep1	14380-156B6	94.86	0.00	4.31
hIPS, biol_rep2	14381-156B7	67.90	0.69	0.69
hIPS, biol_rep3	14382-156B8	55.17	2.21	5.52
hairy cell leukemia cell line:Mo	10712-109I1	32.18	5.75	5.46
heart - mitral valve, adult	10205-103F7	32.29	1.79	0.00
heart - pulmonic valve, adult	10206-103F8	29.55	1.05	0.78
heart - tricuspid valve, adult	10207-103F9	19.15	3.33	0.83
heart, adult, diseased post-infarction, donor1	10050-101G5	66.93	4.08	3.47
heart, adult, diseased, donor1	10051-101G6	56.21	2.13	1.70
heart, adult, pool1	10016-101C7	38.64	1.61	0.69
heart, fetal, pool1	10046-101G1	57.30	1.64	1.85
hepatic mesenchymal tumor cell line:LI90	10778-110G4	26.84	1.23	0.31
hepatoblastoma cell line:HuH-6	10633-108I3	4.76	1.19	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	29.28	2.32	0.99
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	29.01	3.64	1.58
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	29.91	2.02	0.51
hepatoma cell line:Li-7	10484-107A7	90.86	3.78	1.00
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	38.59	2.91	1.81
hippocampus - adult, donor10196	10169-103B7	43.53	2.84	1.89
hippocampus, adult, donor10252	10153-102I9	56.33	2.04	1.02
hippocampus, adult, donor10258	10374-105G5	56.77	1.00	4.98
hippocampus, newborn, donor10223	10363-105F3	34.19	0.70	3.52
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	118.41	8.54	7.32
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	59.89	4.12	4.32
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	54.33	6.35	4.57
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	55.82	5.07	4.51
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	60.42	5.94	2.32
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	91.49	5.69	4.56
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	51.09	8.17	3.50
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	49.76	4.31	3.66
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	50.05	2.09	2.92
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	82.40	10.89	6.87
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	61.55	7.07	4.18
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	62.62	6.06	5.39
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	49.61	3.91	2.66
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	68.29	1.97	4.91
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	146.62	7.85	9.60
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	57.85	4.77	3.44
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	61.92	4.36	4.36
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	106.95	5.00	1.50
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	47.10	5.65	3.77
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	61.39	4.09	6.82
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	80.19	9.40	5.95
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	96.02	8.17	9.31
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	104.22	8.42	13.06
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	97.45	12.26	6.58
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	65.95	5.54	3.33
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	69.04	5.71	3.71
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	131.07	5.31	5.72
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	71.12	4.93	5.99
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	64.30	6.65	3.17
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	88.06	7.87	5.14
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	67.23	6.21	3.62
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	76.38	9.30	5.98
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	50.28	5.39	4.87
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	86.15	7.41	8.18
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	90.87	7.57	11.36
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	101.15	10.42	9.07
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	66.41	4.35	3.62
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	111.41	8.47	4.90
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	100.98	7.80	2.44
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	58.68	6.11	5.20
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	68.32	9.76	9.76
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	102.92	9.60	5.96
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	65.68	3.83	7.66
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	63.33	7.24	6.51
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	85.41	6.41	6.05
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	75.18	3.58	5.97
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	86.00	7.58	10.02
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	79.20	10.51	9.70
immature langerhans cells, donor1	11904-125F5	49.88	0.97	1.21
immature langerhans cells, donor2	11905-125F6	84.76	0.79	0.79
insula, adult, pool1	10039-101F3	54.32	3.79	3.60
keratoacanthoma cell line:HKA-1	10791-110H8	52.35	2.28	1.30
kidney, adult, pool1	10017-101C8	95.72	5.31	2.80
kidney, fetal, pool1	10045-101F9	65.86	4.03	3.61
large cell lung carcinoma cell line:IA-LM	10509-107D5	44.88	1.42	1.42
large cell lung carcinoma cell line:NCI-H460	10839-111E2	46.59	1.94	2.07
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	46.24	3.12	2.39
left atrium, adult, donor1	10079-102A7	34.87	1.63	0.00
left ventricle, adult, donor1	10078-102A6	51.07	0.51	0.00
leiomyoblastoma cell line:G-402	10721-110A1	17.51	0.55	0.82
leiomyoma cell line:10964C	10569-108B2	58.20	4.31	7.54
leiomyoma cell line:15242A	10570-108B3	52.17	7.07	3.80
leiomyoma cell line:15425	10571-108B4	49.05	6.80	3.89
leiomyosarcoma cell line:Hs 5.T	10722-110A2	82.54	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	76.33	11.50	7.32
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	58.56	2.60	1.89
liposarcoma cell line:KMLS-1	10782-110G8	36.40	2.50	2.19
liposarcoma cell line:SW 872	10726-110A6	29.24	0.85	1.10
liver, adult, pool1	10018-101C9	92.70	6.48	1.46
liver, fetal, pool1	10086-102B5	52.68	0.94	0.00
locus coeruleus - adult, donor10196	10182-103D2	46.66	3.50	3.79
locus coeruleus, adult, donor10252	10165-103B3	56.84	2.40	1.29
locus coeruleus, adult, donor10258	10375-105G6	79.56	3.39	7.62
locus coeruleus, newborn, donor10223	10362-105F2	101.79	5.05	2.10
lung adenocarcinoma cell line:A549	10499-107C4	68.51	7.47	4.43
lung adenocarcinoma cell line:PC-14	10408-106B3	78.59	6.20	2.07
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	30.45	1.71	0.66
lung, adult, pool1	10019-101D1	51.50	0.83	0.71
lung, fetal, donor1	10068-101I5	101.89	1.14	2.85
lung, right lower lobe, adult, donor1	10075-102A3	63.69	0.46	0.46
lymph node, adult, donor1	10077-102A5	38.82	0.47	0.00
lymphangiectasia cell line:DS-1	10727-110A7	43.84	5.70	3.29
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	26.71	1.36	2.26
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	30.58	0.00	0.00
mature adipocyte, donor1	12231-129F8	41.29	0.89	1.33
mature adipocyte, donor2	12232-129F9	45.24	2.08	2.70
mature adipocyte, donor3	12233-129G1	41.72	1.19	1.90
mature adipocyte, donor4	12234-129G2	39.75	1.84	3.95
maxillary sinus tumor cell line:HSQ-89	10414-106B9	56.47	6.19	5.72
medial frontal gyrus - adult, donor10196	10170-103B8	24.82	3.38	1.13
medial frontal gyrus, adult, donor10252	10150-102I6	42.48	2.21	2.76
medial frontal gyrus, adult, donor10258	10368-105F8	49.24	2.86	3.81
medial frontal gyrus, newborn, donor10223	10352-105E1	54.59	3.84	4.69
medial temporal gyrus - adult, donor10196	10183-103D3	46.24	3.71	4.05
medial temporal gyrus, adult, donor10252	10156-103A3	43.51	1.70	1.27
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	61.64	3.85	11.56
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	28.71	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	36.61	1.44	2.51
medulla oblongata - adult, donor10196	10174-103C3	79.82	4.54	4.54
medulla oblongata, adult, donor10252	10155-103A2	63.31	2.32	2.48
medulla oblongata, adult, pool1	10038-101F2	61.38	4.65	5.14
medulla oblongata, newborn, donor10223	10361-105F1	149.98	5.55	4.51
medulloblastoma cell line:D283 Med	10838-111E1	22.14	2.66	5.98
medulloblastoma cell line:ONS-76	10759-110E3	23.97	1.10	0.61
melanoma cell line:COLO 679	10514-107E1	25.44	3.02	2.59
melanoma cell line:G-361	10465-106H6	35.29	4.89	4.61
meningioma cell line:HKBMM	10691-109F7	21.89	1.45	1.27
merkel cell carcinoma cell line:MKL-1	10843-111E6	22.91	0.88	2.64
merkel cell carcinoma cell line:MS-1	10844-111E7	84.25	12.96	8.04
mesenchymal precursor cell - adipose, donor1	11747-123G1	60.30	3.84	3.07
mesenchymal precursor cell - adipose, donor2	11748-123G2	34.90	1.82	2.00
mesenchymal precursor cell - adipose, donor3	11749-123G3	53.01	4.14	4.14
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	37.09	1.26	1.83
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	46.22	1.35	3.47
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	62.47	1.39	3.47
mesenchymal precursor cell - cardiac, donor1	11752-123G6	69.00	4.29	5.32
mesenchymal precursor cell - cardiac, donor2	11753-123G7	43.25	2.53	2.30
mesenchymal precursor cell - cardiac, donor3	11754-123G8	57.30	4.24	1.86
mesenchymal precursor cell - cardiac, donor4	11755-123G9	56.58	5.67	2.97
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	38.27	2.85	0.85
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	69.16	3.62	4.28
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	47.05	2.21	1.80
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	47.82	2.79	2.09
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	51.04	3.27	3.47
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	42.78	3.95	2.52
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	45.31	3.31	2.38
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	60.19	5.24	1.60
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	54.96	3.36	5.03
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	46.77	2.84	1.94
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	45.60	2.01	2.19
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	30.19	2.58	2.95
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	36.91	4.01	2.58
mesenchymal stem cell line:Hu5/E18	10568-108B1	54.31	6.74	3.79
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	52.97	3.65	3.20
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	57.55	4.09	2.56
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	46.85	4.97	2.62
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	64.39	4.01	6.16
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	56.25	3.06	4.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	56.52	2.71	5.75
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	55.41	2.75	2.36
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	51.90	4.63	2.32
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	48.30	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	77.01	4.90	6.35
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	56.22	2.68	3.57
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	53.84	3.12	3.85
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	43.27	0.73	2.93
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	61.76	3.69	3.36
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	54.45	4.91	2.05
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	55.84	3.01	4.30
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	95.70	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	82.64	0.00	5.16
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	59.11	1.95	3.57
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	59.65	5.82	4.36
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	79.96	2.67	2.13
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	49.07	4.09	1.64
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	42.76	3.50	2.33
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	46.17	0.00	2.10
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	53.65	3.97	5.96
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	71.51	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	47.44	2.37	1.19
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	47.52	2.44	2.44
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	0.00	27.05
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	63.97	3.17	1.90
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	46.56	2.41	3.45
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	45.13	0.00	6.45
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	39.92	0.00	3.99
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	65.43	0.00	6.89
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	55.42	2.04	1.63
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	59.58	1.59	1.59
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	36.55	2.36	1.77
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	43.02	1.25	0.94
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	48.12	0.00	4.01
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	44.94	1.18	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	74.47	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	48.19	2.75	3.44
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	57.89	3.96	2.97
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	35.89	2.24	3.36
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	58.52	1.27	1.91
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	62.06	2.01	4.03
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	58.88	4.36	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	59.55	3.80	3.80
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	63.12	2.43	2.43
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	122.01	4.52	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	98.02	0.82	1.65
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	58.14	4.17	3.57
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	48.03	3.89	2.60
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	63.15	1.02	1.02
mesodermal tumor cell line:HIRS-BM	10696-109G3	8.51	0.77	1.55
mesothelioma cell line:ACC-MESO-1	10493-107B7	33.31	7.80	4.02
mesothelioma cell line:ACC-MESO-4	10494-107B8	94.06	9.27	1.85
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	68.38	4.27	4.27
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	256.16	14.39	9.25
mesothelioma cell line:Mero-25	10850-111F4	143.43	13.16	7.26
mesothelioma cell line:Mero-41	10851-111F5	51.58	6.60	6.11
mesothelioma cell line:Mero-48a	10852-111F6	40.08	4.21	5.76
mesothelioma cell line:Mero-82	10853-111F7	104.60	5.78	2.89
mesothelioma cell line:Mero-83	10854-111F8	94.30	4.60	2.21
mesothelioma cell line:Mero-84	10855-111F9	22.75	3.29	2.78
mesothelioma cell line:Mero-95	10856-111G1	60.25	2.90	3.93
mesothelioma cell line:NCI-H2052	10847-111F1	27.33	4.14	4.14
mesothelioma cell line:NCI-H226	10846-111E9	43.44	4.71	1.63
mesothelioma cell line:NCI-H2452	10848-111F2	54.32	5.98	3.42
mesothelioma cell line:NCI-H28	10845-111E8	47.08	10.69	14.25
mesothelioma cell line:No36	10857-111G2	59.37	5.22	3.59
mesothelioma cell line:ONE58	10858-111G3	28.72	2.98	1.08
migratory langerhans cells, donor1	11901-125F2	54.31	4.22	4.80
migratory langerhans cells, donor2	11902-125F3	39.81	5.62	3.54
migratory langerhans cells, donor3	11903-125F4	29.43	1.62	3.05
mixed mullerian tumor cell line:HTMMT	10689-109F5	38.20	2.29	0.98
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	71.85	5.51	0.85
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	29.72	3.46	0.23
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	27.21	1.90	1.90
myelodysplastic syndrome cell line:SKM-1	10772-110F7	114.39	5.54	3.70
myeloma cell line:PCM6	10474-106I6	90.33	5.73	5.34
myxofibrosarcoma cell line:MFH-ino	10600-108E6	51.24	1.52	2.03
myxofibrosarcoma cell line:NMFH-1	10684-109E9	118.66	5.69	6.08
nasal epithelial cells, donor1, tech_rep1	12226-129F3	48.80	5.24	2.56
nasal epithelial cells, donor1, tech_rep2	12226-129F3	59.79	7.65	2.35
nasal epithelial cells, donor2	12227-129F4	28.15	1.10	0.55
neuroblastoma cell line:CHP-134	10508-107D4	25.08	2.53	5.52
neuroblastoma cell line:NB-1	10539-107G8	43.40	6.55	5.05
neuroblastoma cell line:NBsusSR	10607-108F4	78.24	9.49	4.64
neuroblastoma cell line:NH-12	10555-107I6	34.10	3.17	5.96
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	26.57	4.27	1.90
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	38.64	1.74	2.85
neuroectodermal tumor cell line:TASK1	10774-110F9	18.11	1.41	0.81
neuroepithelioma cell line:SK-N-MC	10728-110A8	22.89	3.18	0.64
neurofibroma cell line:Hs 53.T	10729-110A9	34.07	1.86	0.53
neutrophil PMN, donor1	12133-128D9	29.75	0.00	0.00
neutrophil PMN, donor2	12137-128E4	119.53	0.00	0.00
neutrophil PMN, donor3	12141-128E8	132.59	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	30.78	0.68	1.01
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	274.57	44.83	37.62
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	73.74	3.21	1.60
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	55.71	2.63	2.63
nucleus accumbens, adult, pool1	10037-101F1	45.28	4.22	2.62
occipital cortex - adult, donor10196	10172-103C1	39.15	4.12	2.06
occipital cortex, adult, donor10252	10163-103B1	45.08	0.81	1.34
occipital cortex, newborn, donor10223	10355-105E4	45.13	3.28	1.82
occipital lobe, adult, donor1	10076-102A4	39.36	3.67	4.20
occipital lobe, fetal, donor1	10073-102A1	33.90	3.00	3.00
occipital pole, adult, pool1	10036-101E9	45.26	3.07	2.44
olfactory region, adult	10195-103E6	42.41	2.48	2.87
optic nerve, donor1	10277-104E7	26.01	2.00	2.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	59.92	2.62	1.82
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	29.81	3.71	1.51
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	45.38	1.86	0.85
oral squamous cell carcinoma cell line:SAS	10544-107H4	32.80	2.89	3.12
osteoclastoma cell line:Hs 706.T	10704-109H2	44.10	2.35	2.35
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	33.64	2.80	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	27.57	0.85	1.27
ovary, adult, pool1	10020-101D2	47.43	2.10	0.70
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	43.63	3.48	1.83
pancreas, adult, donor1	10049-101G4	60.20	0.00	0.94
pancreatic carcinoma cell line:NOR-P1	10698-109G5	35.22	3.63	1.96
papillary adenocarcinoma cell line:8505C	10437-106E5	50.94	4.43	2.38
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	77.33	5.46	3.15
paracentral gyrus, adult, pool1	10035-101E8	39.35	3.39	2.75
parietal cortex, adult, donor10258	10373-105G4	46.98	3.67	3.67
parietal lobe - adult, donor10196	10171-103B9	25.39	1.88	0.94
parietal lobe, adult, donor10252	10157-103A4	36.20	1.14	1.43
parietal lobe, adult, pool1	10034-101E7	41.77	3.70	2.56
parietal lobe, fetal, donor1	10072-101I9	29.10	2.91	2.91
parietal lobe, newborn, donor10223	10356-105E5	47.48	1.87	1.50
parotid gland, adult	10199-103F1	83.87	1.23	3.08
penis, adult	10200-103F2	39.75	0.00	0.54
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	22.50	4.09	2.60
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	43.13	1.89	1.31
pineal gland - adult, donor10196	10179-103C8	49.02	1.29	0.65
pineal gland, adult, donor10252	10160-103A7	49.15	1.18	0.59
pineal gland, adult, donor10258	10377-105G8	72.11	0.63	0.63
pituitary gland - adult, donor10196	10180-103C9	84.99	5.06	6.07
pituitary gland, adult, donor10252	10162-103A9	63.06	1.56	2.61
pituitary gland, adult, donor10258	10378-105G9	106.41	4.26	5.11
placenta, adult, pool1	10021-101D3	31.50	5.38	2.58
plasma cell leukemia cell line:ARH-77	10840-111E3	27.28	2.65	3.05
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	17.90	2.02	2.18
pons, adult, pool1	10033-101E6	33.48	5.85	4.39
postcentral gyrus, adult, pool1	10032-101E5	49.34	4.18	2.88
promyelocytes/myelocytes PMC, donor1	12132-128D8	43.92	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	369.04	5.51	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	481.17	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	105.17	10.20	3.93
prostate cancer cell line:PC-3	10439-106E7	41.20	5.26	1.82
prostate, adult, pool1	10022-101D4	43.17	0.91	1.54
putamen, adult, donor10196	10176-103C5	51.46	2.12	2.83
putamen, adult, donor10252	10152-102I8	78.43	0.00	1.96
putamen, adult, donor10258, tech_rep1	10372-105G3	63.38	2.19	5.46
putamen, adult, donor10258, tech_rep2	10372-105G3	41.80	2.90	4.59
putamen, newborn, donor10223	10365-105F5	66.72	8.25	2.25
rectal cancer cell line:TT1TKB	10469-106I1	34.62	2.62	0.29
rectum, fetal, donor1	10067-101I4	47.29	1.39	4.17
renal cell carcinoma cell line:OS-RC-2	10411-106B6	50.24	6.36	3.60
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	35.21	2.07	1.66
retina, adult, pool1	10030-101E3	62.62	2.88	1.89
retinoblastoma cell line:Y79	10475-106I7	53.26	1.82	1.30
rhabdomyosarcoma cell line:KYM-1	10787-110H4	50.16	4.18	1.23
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	12.94	4.22	1.97
sacrococcigeal teratoma cell line:HTST	10695-109G2	30.31	0.00	0.76
salivary acinar cells, donor1	11771-123I7	25.90	1.13	1.62
salivary acinar cells, donor2	11772-123I8	27.81	1.65	0.96
salivary acinar cells, donor3	11773-123I9	25.82	1.32	1.32
salivary gland, adult, pool1	10093-102C3	97.80	3.43	4.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	22.85	1.35	1.01
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	25.16	1.65	0.47
seminal vesicle, adult	10201-103F3	53.97	0.53	0.53
serous adenocarcinoma cell line:JHOS-2	10639-108I9	74.58	4.13	4.62
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	67.19	2.01	1.51
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	64.23	7.02	6.02
serous cystadenocarcinoma cell line:HTOA	10693-109F9	86.91	8.87	7.52
signet ring carcinoma cell line:Kato III	10436-106E4	22.99	2.54	1.11
signet ring carcinoma cell line:NUGC-4	10483-107A6	23.35	1.68	1.03
skeletal muscle - soleus muscle, donor1	10282-104F3	12.77	0.71	0.00
skeletal muscle, adult, pool1	10023-101D5	40.66	1.56	0.96
skeletal muscle, fetal, donor1	10066-101I3	41.21	1.01	3.02
skin, adult, donor1	10074-102A2	33.93	6.79	0.00
skin, fetal, donor1	10065-101I2	30.30	0.63	3.16
small cell cervical cancer cell line:HCSC-1	10800-110I8	81.38	14.68	9.01
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	45.07	2.84	6.62
small cell lung carcinoma cell line:DMS 144	10841-111E4	58.40	4.82	6.75
small cell lung carcinoma cell line:LK-2	10541-107H1	24.06	3.96	1.65
small cell lung carcinoma cell line:NCI-H82	10842-111E5	40.86	4.50	5.15
small cell lung carcinoma cell line:WA-hT	10562-108A4	35.08	1.09	1.53
small intestine, adult, pool1	10024-101D6	69.64	2.39	1.55
small intestine, fetal, donor1	10064-101I1	47.91	1.72	0.98
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	135.92	14.36	7.69
smooth muscle, adult, pool1	10048-101G3	29.21	1.03	0.78
somatostatinoma cell line:QGP-1	10781-110G7	35.65	2.41	1.34
spinal cord - adult, donor10196	10181-103D1	44.05	5.05	1.84
spinal cord, adult, donor10252	10159-103A6	48.50	1.58	0.39
spinal cord, adult, donor10258	10369-105F9	114.84	5.53	11.76
spinal cord, fetal, donor1	10056-101H2	42.69	4.88	3.05
spinal cord, newborn, donor10223	10359-105E8	83.12	6.43	5.51
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	28.08	3.14	1.94
spleen, adult, pool1	10025-101D7	46.48	1.10	1.87
spleen, fetal, pool1	10044-101F8	40.84	0.95	1.51
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	18.32	2.28	2.07
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	39.87	1.14	0.38
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	134.54	6.99	4.89
squamous cell carcinoma cell line:T3M-5	10616-108G4	71.54	1.95	1.17
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	78.34	1.91	0.79
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	72.01	4.24	3.81
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	31.31	1.27	0.42
stomach, fetal, donor1	10062-101H8	36.31	1.07	0.00
submaxillary gland, adult	10202-103F4	50.70	2.85	1.71
substantia nigra - adult, donor10196	10178-103C7	54.27	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	48.19	2.70	1.25
substantia nigra, adult, donor10258	10371-105G2	74.48	3.62	5.69
substantia nigra, newborn, donor10223	10358-105E7	67.83	5.65	2.12
synovial sarcoma cell line:HS-SY-II	10441-106E9	62.82	8.71	8.48
temporal lobe, adult, pool1	10031-101E4	61.20	4.07	3.56
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	22.08	1.42	2.85
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	29.01	2.20	1.76
tenocyte, donor1	11763-123H8	49.22	4.19	1.05
tenocyte, donor2	11765-123I1	50.36	1.53	2.29
tenocyte, donor3	11768-123I4	58.94	2.97	3.71
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	46.06	5.27	1.02
teratocarcinoma cell line:NCR-G1	10798-110I6	65.98	1.85	0.77
teratocarcinoma cell line:PA-1	10807-111A6	31.46	2.79	1.24
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	32.50	4.06	2.03
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	53.32	0.76	1.51
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	19.74	0.87	1.31
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	48.86	3.26	1.30
testis, adult, pool1	10026-101D8	180.71	8.59	3.44
testis, adult, pool2	10096-102C6	352.75	19.40	9.02
thalamus - adult, donor10196	10168-103B6	36.43	4.42	0.00
thalamus, adult, donor10252	10154-103A1	54.86	1.72	1.88
thalamus, adult, donor10258, tech_rep1	10370-105G1	118.55	0.00	21.55
thalamus, adult, donor10258, tech_rep2	10370-105G1	51.05	3.62	4.12
thalamus, newborn, donor10223	10366-105F6	42.00	5.18	5.18
throat, adult	10209-103G2	57.67	0.25	2.00
throat, fetal, donor1	10061-101H7	70.69	0.61	2.74
thymic carcinoma cell line:Ty-82	10803-111A2	26.03	0.99	0.20
thymus, adult, pool1	10027-101D9	52.99	2.49	3.48
thymus, fetal, pool1	10043-101F7	44.68	1.87	2.60
thyroid carcinoma cell line:KHM-5M	10776-110G2	108.23	9.71	7.58
thyroid carcinoma cell line:TCO-1	10783-110G9	72.50	3.91	1.40
thyroid, adult, pool1	10028-101E1	72.97	4.01	3.27
thyroid, fetal, donor1	10060-101H6	55.11	3.16	3.16
tongue epidermis (fungiform papillae), donor1	10288-104F9	18.48	0.00	6.16
tongue, adult	10203-103F5	40.70	2.56	2.33
tongue, fetal, donor1	10059-101H5	50.84	2.36	0.79
tonsil, adult, pool1	10047-101G2	68.02	3.41	2.10
trachea, adult, pool1	10029-101E2	170.88	3.52	2.13
trachea, fetal, donor1	10058-101H4	61.94	3.46	1.15
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	37.55	2.48	0.71
transitional-cell carcinoma cell line:5637	10418-106C4	49.24	5.67	1.42
transitional-cell carcinoma cell line:JMSU1	10492-107B6	33.37	2.35	2.04
tridermal teratoma cell line:HGRT	10694-109G1	19.03	1.90	1.90
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	43.17	1.19	1.27
umbilical cord, fetal, donor1	10057-101H3	52.16	0.00	0.00
uterus, adult, pool1	10100-102D1	55.28	1.71	2.56
uterus, fetal, donor1	10055-101H1	30.20	1.02	0.51
vagina, adult	10204-103F6	27.79	0.00	1.29
vein, adult	10191-103E2	30.91	2.19	1.75
xeroderma pigentosum b cell line:XPL 17	10563-108A5	21.36	4.01	2.40